OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

2025-12-31-accounts

Charity number: 1192189 EIG CANCER RESEARCH & SCHOLARSHIP FOUNDATION (A Charitable Incorporated Organisation) UNAUDITED TRUSTEES, REPORT AND FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025

EIG CANCER RESEARCH & SCHOLARSHIP FOUNDATION IA Ch¥4ri1Able Incorporated Organi5ation) COYTE44TS Pa¥e R¢f¢rence 8nd Administrative Details of the Cb*rSty, Its Trustees #nd Advisers Trus¢¢¢s' Report Statement of FiD•D¢i¥I Activities BAIAnet Sheet Notes to the Fingncl41 St#lerntnts 6-10

EIG CANCER RESEARCH & SCHOLARSHIP FOUNDATION (A ChArit*ble Intorporated Organi54tion) REFERENCE AND ADMINi¥fRATIVE DETAIiS OF THE CHARITY. ITS TRUSTEES AND ADVISERS FOR THE YEAR ENDED 31 DECEMBER 2025 Trustees Spiros Giamas. Trusiee and Chairman Menelaos Giamax TTusiee Christopher Chrisiou. Trustee Robert Soieriou. Trustee Piero Soteriou, Trusiee Ch8rity reglsiered number 1192189 R¢gi$t¢red office 253 Grays Inn Road London WCIX 8QT Solici¢or4 Nahlis chri￿0￿ LLP 24.1 Grays Inn Road London WCIX8RB Page I

EIG CANCER RESEARCH & SCHOLARSHIP FOUNDATION {A Ch8rit8ble Incorpornted Ory¥nisatlo￿) TRUSTEES, REPORT FOR THE YEAR ENDED 31 DECEMBER202S The Trustees are pleased to present their annual report together with the financial SEatements of the EIG Cancer Research & Scholarship Foundation Iihe 'Chariiy} for the year ended 31 December 2023. The Charity is constituted as a Charitable Incorporated Organisation {CIOI. The Annual ineludes a Trnsi¢¢s' r¢port. The Trustees confirm that the Annual Report and financial s¢a¢ements of the Charitable ¢ompany ¢omply with ihe ¢urrent statutory requirements, the requirements of the char¥table cotnpan￿5 go￿"¢Ming document and the provi5ion5 of the Sraiement of Reconimended Practice ISORPI applicable to charitie5 preparing iheir accounts in accordance with ihe Financial Reporting Standard applicable in the UK and Republic of Ireland IFRSIO?) (effective l jan￿ary 20191. Obj¢¢tiv¢s and Acttwities Policies aud objectives The objea of the Charity 15 for the public benefii to ad￿an£t educaiioll by Ihe provision of financial support io assisi individuals in f￿rtherIng their posi 8fdduaie studies and research in the fleld of &2ncer rela￿1 siudies and research ai recognized llniversities, colleges. hospilals, reSea￿h organisatiofts and similat ins¢itutlQll5 in the United Kingdom and elsewhere and io provide finan¢ial support to those insiitulions in connection with cancer related studies and research. In settin8 objectives and planning for activities. Ihe Tru5ttes have given due considerdiion to general guidance published by the Charity Commission relating io public benefiL including the guid8n¢e'Publi¢ benefit= runThing a charity (PB21'. b. SIrnt￿l¢s for #¢hieving objectives The Strategie$ for a¢hi¢ving th¢ Charity's obje¢iives are io Taise ￿ndS through dorkations from organisations and individuals and io provide grants and donations io individuals and institutions that fall within the Charity's r¢mii. ¢. A¢tivities undertgken to Schieve objectives The Twst¢es have concentrated on estsblishing the Chariiy and rea¢hing out to EM)tential donors and have made grants and donatiotis in ac¢ordan¢e with the Charily's tsbje¢tiN'es. Ih¢ Tru5tee5 illtend to focus on promoting the Charity through networking and holding ￿riodIc fundrai5Lng events. d. GraDt-makiDg policies The Tru5tee5 have agrecd Grnnt Making and Educational Re5e4rch w)lÉcies. Th¢s¢ wli¢ies have been based largely on guid¢lin¢s is5Utd by the Charity Commission. . Main Activities UDdertaken to further the Charity's purposes for the public benefit All of the Charity's a¢tivi¢ies are f¢x ¢he public benefit through its facilitation of tsrgeted knowledg¢ and researth in the public domain. A¢hiev¢ment$ and perf0rn14net Main achievements of the Charity The main achievements of the Charity during the year have been io make grants and donations and develop its operaiional strate8ie5. Durin8 the year. a 8fdni of £9,000 was mad¢ to a PhD cancer researcher. Pa¥¢ 2

EIG CAP4CER RESEARCH & SCHOLARSHIP FOUNDATION (A Chrit¥ble Intorpor4¢¢d 0￿￿￿tiOn) TRUSTEES, REPORT (CONTINUED) FOR THE YEAR ENDED31 DECEMBER 21125 Financial review Going cone¢rn After moking appropriaie enquiries. Ihe Tn]si¢¢s have a reasonable exp¢ciation ihol the Charity has adequaie rewurces io coThtinue in operational exisien¢¢ for ihe for¢s¢¢able fuiure. For this reason. Ih¢y ¢oniinu¢ to adopi ihe going LonceTn basis in preparin¥ tht financial siatemenis. Further de¢wls rewding the adopiion or Ihe goin¥ Concern btisis can k found in Ihe i¢¢ountin8 policies. b. Reserves poli¢y The primary intention of the Charity is to disiribuie its funds to med its Charitsble objeaives. It is prudent however to re￿in sufficient fund5 to ensure ihe ¢onlinuiTy of ils operations. In this early s¢a¥e of the Charily's estsblishnieni tlii5 aspeci is ¢los¢ly monitored by the Trustees. Structure. 8overts#nee management Con$titu¢ion EIG Cancer Research & Scholarship Foundhiion is regisiered as a Charithble In¢orpor8ied Organisation {ClOI. b. Methods of 4ppolntm¢nt or eleetlon of Try$l¢es The rnana8ement of the Charity is the ttsponsibility of the Tru$iees who are el¢￿ed under the temis Of th¢ CIO Constitution. Stalem¢n¢ of Trujttes, responsibilities The Trustees are responsible for preparing ihe Trustees, Report and the fiThanctal slalements in ac¢ord8n¢¢ wilh applicable law and Uniied Kingdom A¢¢ouniinB Standards (United Kingdom Gen¢rdlly A¢¢epi¢d A¢couniing Praciicel. The Charities Act 2011 requires ihe Trusi¢¢s ¢0 pr¢p8re financial swiements for each financial Y￿r. In preparin8 these flnancial s¢aiements, the Tms*es have followed besi pra¢iise which requires them to: s¢le¢i suitable ac¢O￿n11nS policies and then apply Ihern consisi¢nily.' observe the methods and principles of the Charitie5 SORP- make jud8ments and accountin8 estimale5 that are reasonable and prndent: stat¢ whether applicable UK Accountin8 Standards IFRS 102) have been followed. subjea to any material departurts di5clo%d and explained in the financial stateTnents'. prepare the financial statemcnts on the going ¢on¢em basis unlcs5 bt is tnappropriate to presume that the CIO will continue in bu$in¢ss. The Trus(ees are rtsponsible for keepin8 adeq￿1£ accouniiThg records ihai are suffjeieni io show and ¢xplain the C.10'5 Iran5actions and disclose with r¢a50nable arcuTary at any tirne the financial p051tÉon of the CIO and enable them io ensure that the flnancial s omply with th¢ Charilits Ac 2011. They are a150 responsible for safe8uardin8 the ass￿$ of the CIO and hence ing rea50nY4blc step5 for the prevention and deteciion of fraud and other irr¢8ulariii¢s. Approved b or ember5 of the board of Trullees on 29 Seplember 2026 and signed on their behalf by.. Piero Soteri . Trustee Page 3

EIG CANCER RESEARCH & SCHOLARSHIP FOUNDATION (A Cb•rii¥bl¢ ltttorp)nted Orggllisx¢iott} STATEMENT OF FINANCIAL AcfivJTIES (IWCORPOK4TINC INCOME AND EXPENDITURE ACCOLNT) FOR THE YEAR ENDED 31 DECEMBER 21125 Uttr¢stricied ruvd$ 2025 Total fund$ 2025 Total funds 2024 Incorne from: Donations and le8a¢ies 14,790 14,790 32.337 Totsl iDeome 14,790 14,790 32.337 Exp¢nditure on: Charirabl¢ a¢tivities 20,124 20,124 49,411 Total expenditure 20.124 20.124 49.41 Net mov¢m¢nt ID funds 1SJ34> 1SJ341 {17.0741 Reconcili8tion of funds: Tothl funds brought forward Nei movement in funds 2,520 2,520 15J34) 19,594 (17.074) Totsl funds c#rried forw*rd {2,814> 12,8141 2,520 The Siat¢meni of Financial Activitl¢S Lncludes all gain5 and 1055¢5 r￿0g￿l￿d in the year. The noies on pages 6 10 10 forni part of these financial statements. Pagc 4

EIG CANCER RESEARCH & SCHOLARSHIP FOtiYDATION (A Charitable Incorporated Organisationl REGISTERED INbllBER: B.4LANCE SHEET AS AT 31 DECE%IBER 2024 2025 2024 Note Fixed assets Current assets Debiors 796 Cash at bank and in hand 5,069 5.865 Creditor5'. amounts falling due within one year (6.480) {3,3451 N¢t current liAbilxties l 8ssetS (2,814> 2.520 Tot#1 #sstt$ less <yrr¢nt liabilities 12.814} 2,520 N¢t liabilities l 8ssets excluding Pensio￿ asset (2,8141 2.520 Tot#1 utt #$sets 12.814} 2,520 Charity fuud$ Restricted ￿ndS Unre5tri¢ted funds 12,8141 2.520 Total fund$ {2,8141 2.520 The Charity was entitled to excmption from audit under section$ 144 and 145 of the Charities Act 2011. The Trustees have not required the Charity lo obtain an audit for the period in question in aceordance with sections 144 and 145 of Charities Act 201 I. Tht Trustets acknowledge ihetr r¢swnsibJlili¢s for ¢omplying with the requirements of the Charites Act 2011 with respect to accounting records and p￿paratIon of financial statcments. The finan their beha ments were approved and authorised fv issue by the Trusiees on 29 September 2026 and sign¢d on Piero Soteriou, Trnstee The notes on pages 6 to 10 form part of these finan¢ial siat¢m¢nts. Page 5

EIG CANCER RESEARCH & SCHOLARSHIP FOUNDATION (A Charii#bl¢ l¢orportrd Orgois1iiots) NOTES TO THE FINANCIAL STATEMENTS FOR THE I'EAR ENDED 31 DECEMBER2025 Genernl lrtform#iion The Charity is constiiuied as a Chari18ble In¢orpordi¢d Incorporation ICIOI under ihe Charities Act 201 l and is re8lStered with the Charity Commission For England and Wales regisi¢red numbe¥ 1192189. The CIO was regisi¢r¢d on 5 November 2020. Atcountlng poli¢i¢s 2.1 Bsls of pr¢prtion of financlal 5t*temeThts The financial stgiements have been prepared in accordance wilh ihe Chariiies SORP {FRS 1021- Accountin and Reponing by Chariiies.. Siaiemeni of Recommended Prnctice applicable 10 charities preparing their Iccount5 in a¢cordan¢¢ wilh ihe Finoncial Reporting Standard appli¢able in th¢ UK and Republic of Ireland {FRS 1021 leffec¢ivv l January 20191. Ihe Financial Reporting Siandard appli¢abl¢ in the UK and R¢publi¢ of Ire14nd {FRS 1021 and Ihe Charities Ad 2011. EIG Can¢er Reseawh & Scholarship Foundaiion meers ihe definition of a public benefit entity under FRS 102. Assets and liabiliiies are iniii8lly recognis¢d ai him0r1￿1 wst QT transaciion v4lu¢ un1¢5s oiherwise 51aied irb ihe relevant accouniing ￿)I1¢y. 2.2 Income All incom¢ 15 reco8nised once the Charity has entiilement 10 the income, il is probable that ihe income will be received and Ihe amouni of incom¢ w¢ivable can be rneasured reliably. 2.3 Expendlture Expenditure is recognised once there is a legal or ¢onstruciive obligation to irnnsfer economic benefit to Ihird party. it is probablc that a Iransfer of economic benefits will be r¢quir¢d in settlement and the alliounl of Ihe obligation can be Tnea5ured reliably. Expenditure is clas5ifi¢d by a¢iivity. The costs of each aclivity are made up of lh¢ total of direcl cosis and Shared costs. includin8 SUPPOrt Costs involved in undertakin8 eacli activity. Direci Costs allributable io a sÉngl¢ ad1vi￿ are allocated directly 10 ihai o¢1iviiy. Shar¢d costs which contribute to more than one activity and suppon Costs which are noi aiiribuiable to a single aLliviiy are apportioned between those ￿tIvitIeS on a basis Consistent with the use of restsurces. Central staff Costs are allocated on the b&4is of time spenl. and deprcciation char8e5 allocated on the portion of the asset's use. Ex￿ndItUre on charithble a¢iiviiies is incurred on direeily undertoking the a¢iiviiies which funher ihe Charity'5 objectiv￿. a5 well as any associaied support Grants payable are ¢harg¢d in the year when ihe offer is made ex¢ept in thos¢ ¢as¢s Where ihe off¢r is onditional. such grant$ being re¢ognised as expenditure when ihe ¢ondiiions aiiaching are fulfilled. Grants offered subject to conditions whirh have not bren met at the year tnd art noted a5 a commitment. bul iiot accrued as eX￿ndItuT¢. All expEnditure is in¢lu5iv¢ of irre¢owerabl¢ VAT. 2.4 Debtors Trade and other de￿OrS are recognised at the settlement amount after any irade disc4)uni offered. Prepaymenis are valued ai the amount pr¢paid of any trade discounts du¢. Page 6

EIG CANCER RESEARCH & SCHOLARSHIP FOUNDATION (A Charitable IDcorpornted 0￿￿1￿¢10￿> NOTES TOTHE FINANCIAL STATEMEliTS FOR THE YEAR ENDED 31 DECEMBER 2025 Aecounting poli¢i¢s (¢ontinued) 2.5 Liabilities and prowi5l0DS Liabiliti¢s are recognised when ihere is an obligation ai the Balance Sheet date as a result of a pasi event. it is probable that a ¢ransf¢r of e¢onomic benefii will be requtred in setLlemen4 and the amount of th¢ settlemeni can be estimated rtliably. Liabilities are recognised at the amount thai the Charity aniicipaie5 It ivill pay to settle the debt or the amount it has re¢eived as advanc¢d pa)Thenis for the g(x>ds or services it m￿st provide. 2.6 Fund &tcouDting General funds are unrestri¢ied funds wthi¢h ar¢ available for use at the discretion of the Trusi¢es in furtherance of the general obje¢Tives of the ChaDty and ￿hl¢kn have not been designated for other purp05e5. In¢omt from donations received L'nrtSiri¢ted fund5 Total funds 2025 Total funds 2024 Donations 14.7()0 14,79 32,337 ADaly515 of charitable grants m*de Totsl funds 2024 Gra￿ts 2025 Total grants 2025 Scholarship and instituiional 8fdnis and donations 9,0(M) 18,000 Page 7

EIG CANCER RESEARCH & SCHOLARSHIP FOUP4DATION (A Chariibl lJ)¢orpornt¢d Org•ni$ationl NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED3I DECEMBER 202S Analysis of expenditure on ch8ritAble clivitie5 Summary by fund type and #th#ly$i$ of expttsdilure by •c¢ivliles Unr¢strict¢d Toial Total 2024 2025 Scholarship and insiiiuiion81 Grants Adminsiirniive Costs 18.000 11,124 20,124 20,124 49,411 Trustees, r¢muneration ond eip¢ns¢s Durhn8 the year. the Trustees rteeived no remunerniion for their services as trustees. Debiors ?024 Due wlthln on¢ yer Prepayments and a¢cru¢d income 796 790 Creditor5: Amounts fAllin% due within ont ytgr 2024 Trade creditors 3,240 Other rr¢ditors A¢¢ruals and deferred in¢om¢ 264 3.2411 3.000 6,480 Page 8

EIG CANCER RESEARCH & SCHOLARSHIP FOUNDATION (A Charitable IDcorpornted 0￿￿1$#110￿) NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR E%DED 31 DECEMBER 2025 Ststernent of funds stateM¢￿t or runds- turrent year Balgn¢e gt 31 December B#l#llce #i Januan. 2025 Incorne Expenditure Unrestricted funds General Fund5- all funds 2520 14.790 120.124) (2,8141 Statement of fund5- prior year Balance at 31 Decernb¢T 2024 Balance at l January 2024 Income Expenditure Unrestritted funds General Funds- all funds 19.594 32.337 {49.4111 2.520 Analysis of net assets betsveen funds Unrestritted fund$ 2025 Tolal fund5 202S CutT¢n¢ assets Cr¢dtttsrs due wiihin one year .3,666 (6,480) 3.666 {6.4801 Totsl 12,814) (2,8141 Page 9

EIG CANCER RESEARCH & SCHOLARSHIP FOUN'DATION (A Ch8ritable IDcorpor*ted Org8ni58tion) NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED31 DECEMBER 2025 io. Analysis of net Assets betwetn fu￿dS (tontinued) Analysi5 of Det #ssets bt¢w¢¢o fuod$- prior yea Unrestricted funds 2024 Total funds 2024 Current assets Creditors due within one year 5.865 {3,3451 5.865 13.3451 Total 2.520 2,520 Page 10